BIOFAC A/S: Financial statements 2024
CVR: 62550511
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
BIOFAC A/S (CVR 62550511) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 65,665,318 and a net result of DKK 332,520 compared with DKK 1,609,606 the year before. That is an increase of 76.2% compared with the year before. Equity in the 2024 report amounted to DKK 14,586,272. The solvency ratio was 9%. The company had 75 employees in the financial year.
- Gross Profit
- DKK 65,665,318
- Profit/Loss
- DKK 332,520
- Equity
- DKK 14,586,272
- Total Assets
- DKK 161,331,470
- Employees
- 75
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 65.7 mio. | 333 t. | 14.6 mio. | 75 |
| 2023 | - | 37.3 mio. | 1.6 mio. | 14.3 mio. | 73 |
| 2022 | - | 20.3 mio. | -6 mio. | 12.6 mio. | 76 |
| 2021 | - | 28.8 mio. | -1.1 mio. | 18.6 mio. | 71 |
| 2020 | - | 23.4 mio. | -4.2 mio. | 19.7 mio. | 68 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOFAC A/S
BIOFAC A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1934. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 83 employees (2026). In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. Equity in the 2025 report amounted to DKK 10,810,382.